Company Filing History:
Years Active: 2013
Title: Erling Falk: Innovator in Atherosclerosis Research
Introduction
Erling Falk is a notable inventor based in Harlev, Denmark. He has made significant contributions to the field of medical research, particularly in the study of atherosclerosis. His innovative work has led to the development of a unique genetically modified pig model that aids in understanding this complex disease.
Latest Patents
Erling Falk holds a patent for a "Pig model for atherosclerosis." This invention relates to a genetically modified pig that serves as a model for studying atherosclerosis. The modified pig exhibits one or more phenotypes associated with the disease. The patent also discloses a modified pig that includes mutations in the endogenous ApoE gene, LDL gene, LDL receptor gene, or their respective transcriptional or translational products. Furthermore, the invention outlines methods for producing the modified pig, evaluating therapeutic treatments for atherosclerosis, screening the efficacy of pharmaceutical compositions, and treating humans suffering from the condition. He has 1 patent to his name.
Career Highlights
Erling Falk is affiliated with Aarhus Universitet, where he continues to advance his research in atherosclerosis. His work is pivotal in bridging the gap between genetic research and practical medical applications.
Collaborations
He has collaborated with esteemed colleagues such as Jacob Fog Bentzon and Charlotte Brandt Sørensen, contributing to a rich environment of innovation and discovery.
Conclusion
Erling Falk's contributions to atherosclerosis research through his patented pig model exemplify the intersection of genetics and medicine. His work not only enhances our understanding of the disease but also paves the way for future therapeutic advancements.